Log in to save to my catalogue

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical...

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f1d6935c31ae4661b4595e384c496c95

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold

About this item

Full title

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold

Publisher

United States: John Wiley & Sons, Inc

Journal title

Annals of clinical and translational neurology, 2025-02, Vol.12 (2), p.345-354

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objective
To investigate retinal layer thinning as a biomarker of disease‐modifying treatment (DMT) effects in relapsing multiple sclerosis (RMS).
Methods
From an ongoing prospective observational study, we included patients with RMS, who (i) had an optical coherence tomography (OCT) scan within 6 to 12 months after DMT start (rebaseline)...

Alternative Titles

Full title

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f1d6935c31ae4661b4595e384c496c95

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f1d6935c31ae4661b4595e384c496c95

Other Identifiers

ISSN

2328-9503

E-ISSN

2328-9503

DOI

10.1002/acn3.52279

How to access this item